Page last updated: 2024-08-23

staurosporine and Dwarfism, Thanatophoric

staurosporine has been researched along with Dwarfism, Thanatophoric in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adelsperger, J; Anderson, KC; Chen, J; Coburn, A; Cohen, S; Duclos, N; Fabbro, D; Gilliland, DG; Griffin, JD; Huntly, BJ; Kutok, JL; Lee, BH; Mitsiades, CS; Moore, S; Okabe, R; Williams, IR	1

Other Studies

1 other study(ies) available for staurosporine and Dwarfism, Thanatophoric

Article	Year
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies. Oncogene, 2005, Dec-15, Volume: 24, Issue:56 Topics: Animals; Bone Marrow Transplantation; Cell Line, Tumor; Disease Models, Animal; Growth Inhibitors; Hematologic Neoplasms; Lymphoma, B-Cell; Mice; Multiple Myeloma; Myeloproliferative Disorders; Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Recombinant Fusion Proteins; Staurosporine; Thanatophoric Dysplasia; Transfection	2005

Article

Year

FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies.

Oncogene, 2005, Dec-15, Volume: 24, Issue:56

Topics: Animals; Bone Marrow Transplantation; Cell Line, Tumor; Disease Models, Animal; Growth Inhibitors; Hematologic Neoplasms; Lymphoma, B-Cell; Mice; Multiple Myeloma; Myeloproliferative Disorders; Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 3; Recombinant Fusion Proteins; Staurosporine; Thanatophoric Dysplasia; Transfection

2005